Emcure and Roche Collaborate to Improve Access to Advanced Nephrology Care
Emcure Pharmaceuticals has entered into a distribution agreement with Roche India for select products in nephrology and transplantation, marking a strategic step in expanding...
Lilly’s Obesity Portfolio Wins Full U.S. Insurance Coverage, Reshaping the GLP-1 Landscape
In a pivotal shift for the obesity treatment market, Eli Lilly and Company (NYSE: LLY) has secured formulary coverage across all three of America's...
Dabur India Plant Under US FDA Scanner Over Contamination Concerns
The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility in Silvassa, Dadra and Nagar Haveli,...
FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI
Wockhardt Limited announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic for treating adults with complicated urinary...
FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs
The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing in nonclinical safety assessments for certain...
AbbVie’s DECNUPAZ™ got Approval from FDA: First and Only Antibody-Drug Conjugate (ADC) Treatment
AbbVie (NYSE: ABBV) announced that the U.S. Food and Drug Administration (FDA) has approved DECNUPAZTM (pivekimab sunirine-pvzy), first and only antibody-drug conjugate (ADC) drug for the treatment of Blastic Plasmacytoid Dendritic Cell...